These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 31136893)

  • 21. Design, synthesis and biochemical evaluation of novel carbonic anhydrase inhibitors triggered by structural knowledge on hCA VII.
    Mancuso F; Di Fiore A; De Luca L; Angeli A; De Simone G; Supuran CT; Gitto R
    Bioorg Med Chem; 2021 Aug; 44():116279. PubMed ID: 34216985
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design and synthesis of novel 1,3-diaryltriazene-substituted sulfonamides as potent and selective carbonic anhydrase II inhibitors.
    Lolak N; Akocak S; Bua S; Koca M; Supuran CT
    Bioorg Chem; 2018 Apr; 77():542-547. PubMed ID: 29462772
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carbonic anhydrase inhibitors: Design, synthesis and structural characterization of new heteroaryl-N-carbonylbenzenesulfonamides targeting druggable human carbonic anhydrase isoforms.
    Buemi MR; De Luca L; Ferro S; Bruno E; Ceruso M; Supuran CT; Pospíšilová K; Brynda J; Řezáčová P; Gitto R
    Eur J Med Chem; 2015 Sep; 102():223-32. PubMed ID: 26276436
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structural study of interaction between brinzolamide and dorzolamide inhibition of human carbonic anhydrases.
    Pinard MA; Boone CD; Rife BD; Supuran CT; McKenna R
    Bioorg Med Chem; 2013 Nov; 21(22):7210-5. PubMed ID: 24090602
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Indapamide-like benzenesulfonamides as inhibitors of carbonic anhydrases I, II, VII, and XIII.
    Čapkauskaitė E; Baranauskienė L; Golovenko D; Manakova E; Gražulis S; Tumkevičius S; Matulis D
    Bioorg Med Chem; 2010 Nov; 18(21):7357-64. PubMed ID: 20926301
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Carbonic anhydrase inhibitors. Aromatic/heterocyclic sulfonamides incorporating phenacetyl, pyridylacetyl and thienylacetyl tails act as potent inhibitors of human mitochondrial isoforms VA and VB.
    Güzel O; Innocenti A; Scozzafava A; Salman A; Supuran CT
    Bioorg Med Chem; 2009 Jul; 17(14):4894-9. PubMed ID: 19539481
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis 4-[2-(2-mercapto-4-oxo-4H-quinazolin-3-yl)-ethyl]-benzenesulfonamides with subnanomolar carbonic anhydrase II and XII inhibitory properties.
    Bozdag M; Alafeefy AM; Carta F; Ceruso M; Al-Tamimi AS; Al-Kahtani AA; Alasmary FAS; Supuran CT
    Bioorg Med Chem; 2016 Sep; 24(18):4100-4107. PubMed ID: 27396930
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anticonvulsant 4-aminobenzenesulfonamide derivatives with branched-alkylamide moieties: X-ray crystallography and inhibition studies of human carbonic anhydrase isoforms I, II, VII, and XIV.
    Hen N; Bialer M; Yagen B; Maresca A; Aggarwal M; Robbins AH; McKenna R; Scozzafava A; Supuran CT
    J Med Chem; 2011 Jun; 54(11):3977-81. PubMed ID: 21506569
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carbonic anhydrase inhibitors. Phenacetyl-, pyridylacetyl- and thienylacetyl-substituted aromatic sulfonamides act as potent and selective isoform VII inhibitors.
    Güzel O; Innocenti A; Scozzafava A; Salman A; Supuran CT
    Bioorg Med Chem Lett; 2009 Jun; 19(12):3170-3. PubMed ID: 19435663
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Carbonic anhydrase inhibitors: X-ray crystal structure of a benzenesulfonamide strong CA II and CA IX inhibitor bearing a pentafluorophenylaminothioureido tail in complex with isozyme II.
    Di Fiore A; De Simone G; Menchise V; Pedone C; Casini A; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2005 Apr; 15(7):1937-42. PubMed ID: 15780637
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chalcogenides-incorporating carbonic anhydrase inhibitors concomitantly reverted oxaliplatin-induced neuropathy and enhanced antiproliferative action.
    Tanini D; Carradori S; Capperucci A; Lupori L; Zara S; Ferraroni M; Ghelardini C; Mannelli L; Micheli L; Lucarini E; Carta F; Angeli A; Supuran CT
    Eur J Med Chem; 2021 Dec; 225():113793. PubMed ID: 34507012
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and biological evaluation of novel aromatic and heterocyclic bis-sulfonamide Schiff bases as carbonic anhydrase I, II, VII and IX inhibitors.
    Akocak S; Lolak N; Nocentini A; Karakoc G; Tufan A; Supuran CT
    Bioorg Med Chem; 2017 Jun; 25(12):3093-3097. PubMed ID: 28400084
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis of different thio-scaffolds bearing sulfonamide with subnanomolar carbonic anhydrase II and IX inhibitory properties and X-ray investigations for their inhibitory mechanism.
    Angeli A; Tanini D; Capperucci A; Malevolti G; Turco F; Ferraroni M; Supuran CT
    Bioorg Chem; 2018 Dec; 81():642-648. PubMed ID: 30253337
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design and synthesis of novel benzenesulfonamide containing 1,2,3-triazoles as potent human carbonic anhydrase isoforms I, II, IV and IX inhibitors.
    Kumar R; Vats L; Bua S; Supuran CT; Sharma PK
    Eur J Med Chem; 2018 Jul; 155():545-551. PubMed ID: 29909339
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carbonic anhydrase inhibitors: synthesis and inhibition of the human carbonic anhydrase isoforms I, II, VII, IX and XII with benzene sulfonamides incorporating 4,5,6,7-tetrabromophthalimide moiety.
    Sethi KK; Vullo D; Verma SM; Tanç M; Carta F; Supuran CT
    Bioorg Med Chem; 2013 Oct; 21(19):5973-82. PubMed ID: 23965175
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discovery of Benzenesulfonamides with Potent Human Carbonic Anhydrase Inhibitory and Effective Anticonvulsant Action: Design, Synthesis, and Pharmacological Assessment.
    Mishra CB; Kumari S; Angeli A; Monti SM; Buonanno M; Tiwari M; Supuran CT
    J Med Chem; 2017 Mar; 60(6):2456-2469. PubMed ID: 28253618
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structural study of the location of the phenyl tail of benzene sulfonamides and the effect on human carbonic anhydrase inhibition.
    Güzel-Akdemir O; Biswas S; Lastra K; McKenna R; Supuran CT
    Bioorg Med Chem; 2013 Nov; 21(21):6674-80. PubMed ID: 24012377
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Benzenesulfonamide bearing 1,2,4-triazole scaffolds as potent inhibitors of tumor associated carbonic anhydrase isoforms hCA IX and hCA XII.
    SitaRam ; Celik G; Khloya P; Vullo D; Supuran CT; Sharma PK
    Bioorg Med Chem; 2014 Mar; 22(6):1873-82. PubMed ID: 24560737
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis of novel acridine bis-sulfonamides with effective inhibitory activity against the carbonic anhydrase isoforms I, II, IX and XII.
    Esirden İ; Ulus R; Aday B; Tanç M; Supuran CT; Kaya M
    Bioorg Med Chem; 2015 Oct; 23(20):6573-80. PubMed ID: 26422787
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pyridazinone substituted benzenesulfonamides as potent carbonic anhydrase inhibitors.
    Yaseen R; Ekinci D; Senturk M; Hameed AD; Ovais S; Rathore P; Samim M; Javed K; Supuran CT
    Bioorg Med Chem Lett; 2016 Feb; 26(4):1337-41. PubMed ID: 26804228
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.